New imaging agent could spot esophagus inflammation without biopsy
NCT ID NCT05757856
First seen May 02, 2026 · Last updated May 08, 2026 · Updated 3 times
Summary
This study tested a radioactive imaging agent (NDX-3315 and NDX-3324) to see if it can safely and accurately detect eosinophilic esophagitis, a condition where immune cells build up in the esophagus. It involved 34 healthy adults and patients with the disease. The goal was to compare the imaging results with standard biopsy findings to see if the agent could replace or reduce the need for invasive biopsies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EOSINOPHILIC ESOPHAGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwestern Univerisity
Chicago, Illinois, 60611, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
University of Utah
Salt Lake City, Utah, 84132, United States
Conditions
Explore the condition pages connected to this study.